Among patients with rheumatoid arthritis, the risk for psoriasis was increased after tonsillectomy

Associations of atopic dermatitis with height and BMI decreased by age 14 and 5.5 years, respectively

U.S. population-based prevalence estimate of vitiligo is 0.76 percent; about 40 percent of adults with vitiligo may be undiagnosed

More African Americans seen in cluster 2, which had an inflammatory plasma profile and lower quality of life

Darker skin types underrepresented among publicly available skin image datasets used to inform skin cancer diagnosis

While most report sunscreen use, substantial number also report having had sunburns

Prevalence of asthma, eosinophilic esophagitis, urticaria, rhinitis more than doubled; prevalence increased with AD severity

99.5 percent of a cohort of 242 patients predicted to respond to one or more drug class

Hospital discharges for psoriatic arthritis patients with sepsis, skin and soft tissue infections, and UTIs down from 2012 to 2017 in the U.S.

Randomized clinical trial shows oral nadolol noninferior to oral propranolol for treatment of infantile hemangiomas

Drug is designed to prevent the coronavirus from making copies of itself.

After adjustment for prognostic factors, no association seen between detection by routine skin check and melanoma-specific mortality

Patients with autoimmune bullous skin diseases and COVID-19 have increased three-month mortality risk

About 20 percent of patients who underwent patch testing had relevant reaction

In cohort of individuals with diabetes, no association seen for chronic kidney disease stage 3 to 5 with atopic eczema, psoriasis

Case fatality rate high despite early use of immunosuppressive therapies

Routine sun-protective behaviors not tied to lower BMD; moderate-to-frequent staying in shade linked to reduced prevalence of spine fractures in multivariable model

Hazard ratio for nonmelanoma skin cancer was 2.69 for ruxolitinib-exposed patients; hazard ratio higher for SCC

Presence of two or more of these criteria has a sensitivity and specificity of more than 70 percent, the authors say

Lower serum IgG anti-dsDNA antibody levels seen at 52 weeks with belimumab rather than placebo given after rituximab

Higher body mass index and positive smoking status predict poorer phototherapy response

Vote was nearly unanimous at 17 to 0, with one abstention; FDA expected to make a final ruling in a matter of days

About half of organ transplant recipients who develop one posttransplant skin cancer develop a subsequent skin cancer within two years